Back to Authors

Coutre, Steven E

Mayo Clinic

From Stanford University, Stanford (T.D.S., S.E.C.), the University of California, Irvine, Medical Center, Orange (S.O.), and Kaiser Permanente National Cancer Institute Community Oncology Research Program (NCORP)-Permanente Medical Group, Oakland (C.C.Z.)

Citations 1

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

New England Journal of Medicine | July 31, 2019 | Volume: 381 | Issue: 5 | Pages: 432-443

10.1056/nejmoa1817073 | PMID 31365801